Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer

Immune checkpoint inhibitors (ICIs) are new therapeutic strategies for non-small cell lung cancer (NSCLC). We aimed to quantitatively evaluate the efficacy and safety of ICIs in NSCLC. Pubmed, Embase, Cochrane Library, and Web of Science were searched for randomized clinical trials comparing ICIs wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Wang, Shuai, Hao, Jiatao, Wang, Hao, Fang, Yong, Tan, Lijie
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6136858/
https://ncbi.nlm.nih.gov/pubmed/30221052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1457600
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados